论文部分内容阅读
目的观察曲美他嗪联合辛伐他汀治疗不稳定型心绞痛患者的疗效。方法将本院2009年10月至2011年7月收治的不稳定型心绞痛患者85例随机分为治疗组和对照组,对照组应用常规方法治疗,治疗组在常规治疗的基础上加用曲美他嗪与辛伐他汀治疗。结果经治疗后治疗组总有效率为95.56%,明显优于对照组(85.00%);且经治疗后治疗组患者血脂明显改善,对照组患者血脂无明显变化,两者比较差异有统计学意义(P<0.05)。同时在心绞痛症状的控制及心电图的改善上治疗组均显著优于对照组。结论曲美他嗪联合辛伐他汀治疗不稳定型心绞痛疗效安全、可靠,值得临床推广应用。
Objective To observe the curative effect of trimetazidine combined with simvastatin in patients with unstable angina pectoris. Methods 85 patients with unstable angina pectoris admitted from October 2009 to July 2011 in our hospital were randomly divided into treatment group and control group. The control group was treated by conventional method. The treatment group was treated with Qu Mei Thalizine and simvastatin treatment. Results After treatment, the total effective rate of the treatment group was 95.56%, which was significantly better than that of the control group (85.00%). After treatment, the blood lipid of the treatment group was significantly improved, but there was no significant change in the control group, the difference was statistically significant (P <0.05). At the same time in the control of angina pectoris and ECG improvement in the treatment group were significantly better than the control group. Conclusion Trimetazidine combined with simvastatin in the treatment of unstable angina pectoris is safe and reliable, which is worthy of clinical application.